Field Medical's FieldForce™ Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia.

Field Medical's FieldForce™ Ablation System, the first and only contact force pulsed field ablation (PFA) system, has received FDA TAP Pilot acceptance and Breakthrough Device Designation for its revolutionary approach to treating ventricular tachycardia (VT). This critical advancement is set to redefine care for patients at risk of sudden cardiac death from VT.

Read the full press release here.

LSI Europe '24 Presentation

CEO Steven Mickelsen updated LSI Europe attendees about Field Medical's progress. Watch the full presentation above.

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce™ Ventricular Pulsed Field Ablation Technology

Read the full press release here.